SEARCH HEALTH CONDITIONS BY ALPHABETS
Pancreatogenic Diabetes
Medications for Diabetes, Type 3c
Other names: Pancreatogenic Diabetes; T3cDM; Type 3c Diabetes
About Diabetes, Type 3c: Sort 3c diabetes (pancreatogenic diabetes) is a kind of diabetes mellitus that is caused by disease or damage to the liver.
The pancreas is the organ that produces insulin and glucagon which will keep blood glucose levels balanced. Insulin may help if they are high, reduce blood glucose levels, also glucagon may help if it starts getting low, increase blood glucose sugar levels. An damaged or adrenal gland doesn`t produce enough insulin and glucagon if necessary, or so the individual may have problems with controlling blood glucose levels which could lead to high blood glucose levels (hyperglycemia) or low blood glucose levels (hypoglycemia). The pancreas also has a part in digestion and absorption consequently patients may suffer from difficulties, malabsorption and nutrient deficiencies. The most typical reasons for Sort 3c diabetes is pancreatitis together with different causes of diabetes, hereditary hemochromatosis, cystic fibrosis and cancer after pancreatic surgery.
Drugs Used to Cure Diabetes, Type 3c
This set of medications are somehow associated with, or utilized at the treating this particular condition.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| metforminAway Tag | Rx | B | N | X | Insert review | 0.0 | |
Generic name: metformin systemic Drug class: non-sulfonylureas For users: dose, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information Off-label: Yes | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over the Counter |
| Away Tag | This medication may well not be accepted by the FDA for the treatment of this particular condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to present a risk to the fetus in the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
| C | Animal research studies have demonstrated a negative effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with use in pregnant women clearly outweigh potential gains. |
| N | FDA have not classified the medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| 1 | includes a higher possibility of abuse. Has no accepted medical use in treatment in the United States. There`s just a lack of accepted safety for use under medical supervision. |
| Two | includes a higher possibility of abuse. Includes a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may cause acute physical or emotional dependency. |
| 3 | features a possibility for abuse less than people in programs 1 and 2 two. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | includes a minimal potential for abuse relative to people in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to people in schedule 3. |
| 5 | includes a minimal potential for abuse relative to people in schedule 4. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4 months. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Frazee
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always ask your healthcare provider to make sure the information relates to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
